May 2016 P & T Updates
|
|
- Alyson Farmer
- 5 years ago
- Views:
Transcription
1 Commercial Triple Tier 4th Tier Applicabl e Traditional Detailed s 2 films - DESCOVY tablet NARCAN 2 2 ODEFSEY tablet REPATHA 2 2 HoFH: 3 ml per 28 ROSUVASTATIN UPTRAVI Alternatives abacavir/lamivudine, zidovudine, Epzicom, Truvada sildenafil*, Orenitram*, Tyvaso*, Ventavis*, Letairis*, Opsumit*, Tracleer, Adcirca*, Adempas* VELTASSA packet sodium polystyrene sulfonate VENCLEXTA 3 2 tablets 10 mg tablet: 2 50 mg tablet: 1 tablet 100 mg tablet: 4 1 capsule release, fenoprofen, flurbiprofen, ibuprofen, indomethacin, indomethacin sustained release, ketoprofen, ketorolac, VRAYLAR capsule ZEPATIER tablet, 28 day supply per fill Kaletra, rvir, Aptivus, Viramune, Viramune XR, Videx, Videx EC, Zerit, Evotaz, Reyataz, Sustiva, Fuzeon, Invirase, Atripla, Complera, Emtriva, Genvoya, Stribild, Truvada, Tybost, Viread, Viekta, Edurant, Intelence, Prezcobix, Prezista, Crixivan, Isentress, Combivir, Epivir, Epzicom, Lexiva, Rescriptor, Retrovir, Selzentry, Tivicay,, Trizivir, Viracept, and Ziagen
2 CHIP Tier Detailed s - 2 films - - Alternatives DESCOVY 2 1 tablet abacavir/lamivudine, zidovudine, Epzicom, Truvada NARCAN 2 ODEFSEY 2 1 tablet REPATHA 2 HoFH: 3 ml ROSUVASTATIN 2 - UPTRAVI 2 - sildenafil*, Orenitram*, Tyvaso*, Ventavis*, Letairis*, Opsumit*, Tracleer, Adcirca*, Adempas* VELTASSA 2 1 packet sodium polystyrene sulfonate VENCLEXTA 2 tablets 10 mg tablet: 2 tablets 50 mg tablet: 1 tablet 100 mg tablet: 4 tablets - 1 capsule release, fenoprofen, flurbiprofen, ibuprofen, indomethacin, indomethacin sustained release, ketoprofen, ketorolac, VRAYLAR 2 1 capsule ZEPATIER 2 1 tablet, 28 day supply per fill Kaletra, rvir, Aptivus, Viramune, Viramune XR, Videx, Videx EC, Zerit, Evotaz, Reyataz, Sustiva, Fuzeon, Invirase, Atripla, Complera, Emtriva, Genvoya, Stribild, Truvada, Tybost, Viread, Viekta, Edurant, Intelence, Prezcobix, Prezista, Crixivan, Isentress, Combivir, Epivir, Epzicom, Lexiva, Rescriptor, Retrovir, Selzentry, Tivicay,, Trizivir, Viracept, and Ziagen
3 GHP Family GHP Family Tier Detailed s 2 films daily DESCOVY Brand one tablet daily Alternative(s) abacavir/ Epzicom, Trizivir, Truvada NARCAN Brand 4 naloxone syringe ODEFSEY Brand 1 tablet daily REPATHA Brand ROSUVASTATIN Generic UPTRAVI ASCVS or HeFH: 2 ml HoFH:3 ml per 28 Praluent*, atorvastatin, rosuvastatin, Zetia, cholestyramine, Prevalite, colestipol, fenofibrate, fenofibric acid, gemfibrozil atorvastatin,, lovastatin, pravastatin sildenafil*, Letairis*, Tracleer* VELTASSA Brand one packet daily sodium polystyrene sulfonate VENCLEXTA Brand tablets per 28 Ongoing therapy: four tablets per day Imbruvica*, Revlimid* one capsule daily celecoxib*, diclofenac, difunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, indomethacin, ketoprofen, ketorolac, meloxicam, nabumetone, naproxen, oxaprozin, piroxicam, sulindac, VRAYLAR ZEPATIER Brand one capsule daily one tablet daily for 28 aripiprazole*, clozapine, olanzapine, quetiapine, risperidone, ziprasidone Sovaldi*, Viekira Pak*
4 Geisinger Gold $0 Deductible DESCOVY Specialty NARCAN Brand ODEFSEY Specialty REPATHA Brand UPTRAVI Specialty VELTASSA Brand VENCLEXTA Specialty Standard Detailed s 2 films/day 1 tablet/day 4 nasal sprays/30 1 tablet/day 3 ml/28 Alternative(s) fentanyl patches, morphine sulfate ER, abacavir/ Epzicom, Truvada naloxone syringes/vials Atripla, Complera, Genvoya, Stribild, Praulent*, atorvastatin, rosuvastatin, Zetia sildenafil*, Orenitram*, Tyvaso*, Ventavis*, Opsumit*, Letairis*, Tracleer*, Adcirca*, Adempas*, epoprostenol, Veletri* 1 packet/day sodium polystyrene sulfonate 10 mg tablets = 2/day; 50 mg tablets = 1/day; 100 mg tablets = 4 /day, 30 day supply per fill Arzerra*, Gazyva*, Imbruvica*, Revlimid*, Rituxan*, Zydelig* 1 capsule/day celecoxib, diclofenac sodium, diflunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, meloxicam, nabumetone, naproxen sodium, oxaprozin, VRAYLAR Specialty 1 capsule/day aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone ZEPATIER Specialty 1 tablet/day Viekira*, Sovaldi*, ribavirin, Pegasys, Pegintron
5 Marketplace Tier Detailed s - 2 films - - DESCOVY 3 1 tablet NARCAN 3 ODEFSEY 3 1 tablet REPATHA 3 HoFH: 3 ml per 28 ROSUVASTATIN 2 - UPTRAVI 5 - Alternatives abacavir/lamivudine, zidovudine, Epzicom, Truvada sildenafil*, Orenitram*, Tyvaso*, Ventavis*, Letairis*, Opsumit*, Tracleer, Adcirca*, Adempas* VELTASSA 4 1 packet sodium polystyrene sulfonate VENCLEXTA 5 tablets 10 mg tablet: 2 50 mg tablet: 1 tablet 100 mg tablet: 4-1 capsule release, fenoprofen, flurbiprofen, ibuprofen, indomethacin, indomethacin sustained release, ketoprofen, ketorolac, VRAYLAR 4 1 capsule ZEPATIER 5 1 tablet, 28 day supply per fill Kaletra, rvir, Aptivus, Viramune, Viramune XR, Videx, Videx EC, Zerit, Evotaz, Reyataz, Sustiva, Fuzeon, Invirase, Atripla, Complera, Emtriva, Genvoya, Stribild, Truvada, Tybost, Viread, Viekta, Edurant, Intelence, Prezcobix, Prezista, Crixivan, Isentress, Combivir, Epivir, Epzicom, Lexiva, Rescriptor, Retrovir, Selzentry, Tivicay,, Trizivir, Viracept, and Ziagen
HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily
HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ alafenamide Emtricitabine/
More informationHIV Drugs and the HIV Lifecycle
HIV Drugs and the HIV Lifecycle Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject All HIV drugs work by interrupting different steps in HIV's
More informationNovember 2018 P & T Updates
November 2018 P & T Updates Commercial Triple Tier 4th Tier Applicable Traditional Prior Auth AIMOVIG 3 2 Detailed s 70 mg per month: 2 ml per 60 days 140 mg per month: 2 ml per 30 days AJOVY 3 2 4.5 ml
More informationMidwestern Underwriting Conference 2016
UNDERWRITING HIV: THE FAIRY TALE HAS BECOME REALITY Midwestern Underwriting Conference 2016 Jean-Marc Fix, FSA, MAAA VP, R&D, Optimum Re Insurance Co. AGENDA Where are we with HIV? The risk The ideal case
More informationWOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION
WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION A1. PARTICIPANT ID: ENTER NUMBER HERE - - - ONLY IF ID LABEL IS NOT AVAILABLE A2. VISIT #: A3. VERSION DATE: 1 0 /
More informationDaclatasvir (Daklinza ) Drug Interactions with HIV Medications
Daclatasvir/Sofosbuvir (Daklinza /Sovaldi TM ) Drug Interactions A Quick Guide for Clinicians April 2017 John J Faragon, PharmD, BCPS, AAHIVP Mechanism of Action and Route of Metabolism for Daclatasvir
More informationTHE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work
THE HIV LIFE CYCLE Understanding How Antiretroviral Medications Work DEFINITIONS Host: The animal or cell that another organism lives in. In HIV human CD4 T-cells are the host for HIV. Nucleus: The core
More informationWOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM
WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM ID LABEL HERE ---> VERSION DATE 10/01/07 - - - VISIT #: FORM COMPLETED BY: A1. DATE OF BLOOD DRAW: / / M D Y A2. Do you take
More informationAntiretrovial Crushable/Liquid Formulation Chart
Antiretrovial Crushable/Liquid Formulation Chart Eliza Dollard, PharmD; Nafeesa Chin-Beckford, PharmD; Laura Aragon, PharmD Last Updated: 04/2016 Agent How Supplied Crushable Status **Products listed in
More informationEmblem Medicaid 4th Quarter Formulary Updates
abacavir 20 mg/ml solution Added to Formulary (generic) with Quantity Limits 12/1/2017 abacavir 300 mg tablet Added Quantity Limits 10/1/2017 abacavir-lamivudine 600-300 mg Added Quantity Limits 10/1/2017
More informationCOMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL
Generic Name COMPREHENSIVE ANTIRETROVIRAL TABLE: NUCLOESIDE/TIDE REVERSE TRANSCRIPTASE INHIBITORS (N(t)RTIs) Abacavir ABC (Ziagen) Didanosine ddi (Videx EC) Emtricitabine FTC (Emtriva) Lamivudine 3TC (Epivir)
More informationBLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES
BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies.
More informationOB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION
OB/GYN CHART REVIEW A summary of OB/GYN clinical chart review results designed to monitor the quality of care provided by a Ryan White funded OB/GYN primary care site as part of the Atlanta EMA s quality
More informationCOMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING**, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL
COMPREHENSIVE ANTIRETROVIRAL TABLE: NUCLOESIDE/TIDE REVERSE TRANSCRIPTASE INHIBITORS (N(t)RTIs) Abacavir ABC (Ziagen) Didanosine ddi (Videx EC) Emtricitabine FTC (Emtriva) Lamivudine 3TC (Epivir) Stavudine
More informationALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS
ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS - 2014 Alabama s ADAP formulary offers a minimum of one medication from each HIV antiretroviral class approved by the U.S. Food and Drug Administration (FDA).
More informationANTIRETROVIRAL TREATMENTS (Part 1of
CCR5 CO-RECEPTOR ANTAGONISTS maraviroc (MVC) Selzentry 25mg, 75mg, FUSION INHIBITORS 20mg/mL ANTIRETROVIRAL TREATMENTS (Part 1of 5) oral soln enfuvirtide (ENF, T-20) Fuzeon 90mg/mL pwd for SC inj after
More informationAntiretroviral Dosing in Renal Impairment
Protease Inhibitors (PIs) Atazanavir Reyataz hard capsules 300 mg once daily taken with ritonavir 100 mg once daily No dosage adjustment is needed for atazanavir in renal impairment Atazanavir use in haemodialysis
More informationAppropriate Use & Safety Edits
Appropriate Use & Safety Edits Envolve Pharmacy Solutions provides a variety of safety edits to promote the use of the right medication, in the right patient, at the right time. These edits are routinely
More informationHIV medications HIV medication and schedule plan
Living with HIV (human immunodeficiency virus) It may be scary to find out that you re HIV-positive or have AIDS. Coping with this news may be difficult. Although HIV is a serious infection, people with
More informationNorthwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care
Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care www.nwaetc.org The Northwest AIDS Education and Training Center (NW AETC), located at the University
More information2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)
2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) In some cases, UCare requires you to first try certain drugs to
More informationGenotyping and Drug Resistance in Clinical Practice. Case Studies
Genotyping and Drug Resistance in Clinical Practice Case Studies 12/02 40 year old Hispanic male Dx with HIV 1995 + Hx of PCP > 1x, HepC Medication history: AZT, Crixivan, Videx EC, Sustiva, Zerit, Ziagen,
More informationHIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse
HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs),
More informationHIV and YOU. Special 2008 Update!
HIV and YOU Special 2008 Update! HIV and You Special 2008 Update! In this booklet, you ll see words in bold, red type. Go to the Glossary on the back cover to find out what these words mean. WRITERS AND
More informationHuman Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications
Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications Carrie Allen PharmD, CGP, BCPS, BCPP, CCHP Overview - Part 2: HIV
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationMEDICATION RELATED ISSUES IN THE HIV PATIENT. LEONARD SOWAH, MBChB, MPH, FACP
MEDICATION RELATED ISSUES IN THE HIV PATIENT LEONARD SOWAH, MBChB, MPH, FACP Overview Evalua;on and ini;al of a HIV pa;ent with respect to medica;ons Triaging of pa;ent to determine ideal follow up plan
More informationPage 1 of 5 ENLGLISH / ESPAÑOL / PORTUGUÉS / FRANÇAIS Share 3 Drug Chart for HIV Treatment CURRENT EDITION ABOUT SENSE BACK ISSUES MSMGF HOME CONTACT US There are a number of antiretroviral (ARV) medications
More informationThe ART of Antiretroviral Therapy in Critically-ill Patients with HIV
The ART of Antiretroviral Therapy in Critically-ill Patients with HIV Tyler Finocchio, PharmD, BCPS PGY2 Critical Care Pharmacy Resident Avera McKennan Hospital & University Health Center February 10 th,
More informationAIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010
AIDS Drug Assistance Program ADAP-Miami NEEDS ASSESSMENT July 16, 2010 ADAP Clients - Gender ADAP Clients by Gender FY 09/10 April 2010 to June 2010 26% 0% Males Females 26% 0% Males Females Transgender
More information2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)
2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) In some cases, UCare requires you to first try certain drugs to
More informationHIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options
STRATEGIES FOR THIRD LINE HIV THERAPY issues to consider when faced with few drug options A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Most people living
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationHIV Infection & AIDS in Low- and Middle-Income Countries
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 25: HIV Infection & AIDS in Low- and Middle-Income Countries Author P. Van de Perre, MD, PhD Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues
More informationJULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet
JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationBHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search
BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search Search 1 :When to Initiate ART Covers Questions 1-5 including to prevent transmission Component Description Review area Objectives
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
FUZEON (enfuvirtide) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationOctober 26-28: Training Day 1
Peer Linkage and Re-Engagement of HIV- Positive Women of Color October 26-28: Training Day 1 Peer Linkage and Re -Engagement of HIV - Positive Women of Color Convening Training Trainers Today: Alicia Downes
More informationREIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO
REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO Ont. Drug Distr. Ontario Drug Benefit/Trillium: Other Formulary (F/A) Limited Use (Section 16) Antiretrovirals AZT 100 mg capsules NRTIs (single): Abacavir,
More informationFLORIDA!A MEDICAID' Better Health Care for all Floridians. May
CHARLIE CRIST GOVERNOR FLORIDA!A MEDICAID' Better Health Care for all Floridians HOllY BENSON SECRETARY May 26. 2009 Policy Transmittal: HMO 09-01 Policy Transmittal: PS 09-01 RE: Year Thrcc PerFormance
More informationAn HIV Update Jan Clark, PharmD Specialty Practice Pharmacist
An HIV Update - 2019 Jan Clark, PharmD Specialty Practice Pharmacist 2 The goal of this program is to provide a review and update of HIV care and to provide a forum for discussing the current local and
More informationFORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary
At a Glance: VA ADAP Formulary Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Non Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Multi Class Combination Agents Protease Inhibitors
More informationHIV Management Update 2015
9/30/15 HIV Management Update 2015 Larry Pineda, PharmD, PhC, BCPS Visiting Assistant Professor Pharmacy Practice and Administrative Science ljpineda@salud.unm.edu Pharmacist Learning Objectives Describe
More informationFORMULARY LIST OF COVERED DRUGS
FORMULARY LIST OF COVERED DRUGS 2018 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. HPMS Approved Formulary File Submission ID 00018248, Version Number #3 This formulary
More informationFluconazole dimenhydrinate, diphenhydramine. Raltegravir or dolutegravir with antacids
Supportive therapy Summary of interactions Table 1. Summary of potential interactions between antiretroviral agents and supportive therapy Interactions with enzyme inhibitors (protease inhibitors and elvitegravir/cobicistat)
More informationGuidance for Non-HIV-Specialized Providers Caring for Persons with HIV Displaced by Disasters
Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Displaced by Disasters Visit the AIDSinfo website to access the most up-to-date guideline. Register for e-mail notification of guideline
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationtreatment passport 1
treatment passport 1 Why keep a treatment history? Keeping a short record of your treatment history can help in many ways. It can help you understand your health and treatment. It can help if your doctor
More informationHIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time
STRATEGIES FOR FIRST LINE HIV THERAPY issues to think about when going on therapy for the first time A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Deciding
More informationAIDS DRUG ASSISTANCE PROGRAM (ADAP) FORMULARY - CLIENT VERSION
AIDS DRUG ASSISTANCE PROGRAM (ADAP) FORMULARY - CLIENT VERSION June 9, 2017 (Alternate strengths and dose forms - with exclusion of injectable forms unless the medication is only available in such route
More informationNothing to disclose.
Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital HIV UPDATE FOR THE PRIMARY CARE PROVIDER Nothing to disclose. 1 Outline Epidemiology Screening / testing for HIV
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More informationApproach for the Newly Diagnosed HIV Positive Patient
Approach for the Newly Diagnosed HIV Positive Patient Jason E. Farley, PhD, MPH, ANP-BC, FAAN, AACRN Associate Professor & NP, Johns Hopkins University School of Nursing & Medicine Director, AETC Adult-Gerontology
More informationMedscape's Antiretroviral Pocket Guide for the Treatment of HIV Infection
Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Generic Name (Abbreviation) / Trade Name Abacavir (ABC) / Ziagen Trizivir with ZDV + 3TC Epzicom with 3TC Didanosine (ddi)
More informationFORMULARY LIST OF COVERED DRUGS
FORMULARY LIST OF COVERED DRUGS 2017 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. HPMS Approved Formulary File Submission ID 00017274, Version Number 6 This formulary
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationcontinuing education for pharmacists
continuing education for pharmacists HIV/AIDS: Overview and Resources for Pharmacists Mona T. Thompson, R.Ph., PharmD Volume XXXIII, No. 9 Dr. Mona T. Thompson has no relevant financial relationships to
More informationWELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)
WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015) **To get updated information about the drugs covered by WellCare/ Ohana, please visit our website (https://www.wellcare.com
More informationWorld AIDS Day Year-by-Year Milestones in HIV/AIDS. healthlibrary
World AIDS Day 2014 Year-by-Year Milestones in HIV/AIDS (Adapted from The POZ Timeline: Milestones in the HIV/AIDS Pandemic with additions compiled by Eric Brus, Director of HIV Health Promotion, AIDS
More informationMarch 2017 P&T Updates
March 2017 P&T Updates Commercial Triple Tier 4th Tier Applicable Traditional Prior Auth DICLEGIS 3 No 2 No Yes EMVERM 2 No 2 Yes Yes Detailed s 4 tablets per day, 9 month supply per year Pinworms: 1 tablet
More informationThe ABCs of ART: Designing Initial Antiretroviral Regimens for Beginners
The ABCs of ART: Designing Initial Antiretroviral Regimens for Beginners Elizabeth Sherman, PharmD, AAHIVP Faculty South Florida, Southeast AETC Clinical Pharmacist, Memorial Healthcare System Assistant
More informationDrug Treatment Program Update
Drug Treatment Program Update As of March 211 Drug Treatment Program Update A key component of the Centre s mandate is to monitor the impact of HIV/AIDS on British Columbia. The Centre provides essential
More informationJonathan Cohn MD Wayne State University July 24,
Jonathan Cohn MD Wayne State University July 24, 2017 www.matecmichigan.org jcohn@med.wayne.edu Current HIV Test Sequence 4 th Generation Ag/Ab Combo > Differentiation Assay Abbott Architect Alere Determine
More informationTopical Immunomodulators
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Topical Immunomodulators Clinical Edit Information Included in this Document Topical Immunomodulators Elidel and Protopic 0.03%
More informationAdherence Strategies for Older Adults. AIDS Community Research Initiative of America (ACRIA)
Adherence Strategies for Older Adults AIDS Community Research Initiative of America (ACRIA) June 2008 Modular Objectives By the end of the module, participants will be able to: Define adherence Be able
More informationABRIDGED ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL
NULOESIDE/TIDE REVERSE TRANSRIPTASE INHIBITORS (N(t)RTIs) Abacavir AB (Ziagen) Emtricitabine FT (Emtriva) Lamivudine 3T (Epivir) Tenofovir disoproxil fumarate TDF (Viread) Zidovudine AZT, ZDV (Retrovir)
More informationCHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
More informationGeneric Name Brand Name Restrictions or Notes 1a. ANTIRETROVIRALS-ENTRY INHIBITORS (1) 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(2)
1a. ANTIRETROVIRALS-ENTRY INHIBITORS (1) maraviroc Selzentry 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(2) raltegravir Isentress, Isentress HD dolutegravir Tivicay 1c. ANTIRETROVIRALS-NUCLEOSIDE& NUCLEOTIDE
More informationLesson 3: HIV Poverty
Video Curriculum Modules Lesson 3: HIV Poverty 47 Lesson 3: Poverty Standards: Health: 1.12.2 1.12.3 1.12.6 2.12.4 2.12.10 5.12.2 5.12.4 8.12.1 8.12.3 Science: 7.1 7.5 7.6 8.2 8.3 Overview Poverty has
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationHIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop
HIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop Parya Saberi, PharmD, MAS The Medical Management of HIV/AIDS December 2012 Objectives What are commonly used ARVs and where do they work in
More informationACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
Antiretroviral Medications: What you need to know Jason J. Schafer, PharmD, MPH, BCPS, AAHIVP Associate Professor, Department of Pharmacy Practice Jefferson College of Pharmacy, Thomas Jefferson University
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationCOLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet
COLCRYS-PST Mitigare 0.6 mg capsule Colcrys 0.6 mg tablet Criteria If the patient has tried one Step 1 product, authorization for a Step 2 product may be given. Exceptions can be made for a step 2 drug
More informationAntiretroviral Pregnancy Registry
Preterm Birth, low birth weight and fetal antiretroviral exposure: Estimated gestational age and birth weight data from singleton live births, 1989 through 31 January 2009 K. Beckerman, J. Albano, M. Martinez-Tristani,
More informationDivision of Public Health Services Office of the Assistant Director Public Health Preparedness Services
Division of Public Health Services Office of the Assistant Director Public Health Preparedness Services 150 North 18 th Avenue, #110 JANICE K. BREWER, GOVERNOR Phoenix, AZ 85007-3233 WILL HUMBLE, DIRECTOR
More informationGeneric Name Brand Name Restrictions or Notes 1a. ANTIRETROVIRALS-ENTRY INHIBITORS (2) 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(3)
1a. ANTIRETROVIRALS-ENTRY INHIBITORS (2) maraviroc Selzentry 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(3) raltegravir Isentress, Isentress HD dolutegravir Tivicay 1c. ANTIRETROVIRALS-NUCLEOSIDE& NUCLEOTIDE
More information2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationTrue Health New Mexico List of Medications with Quantity Limits
True Health New Mexico List of Medications with Quantity Limits Specialty Medications Contact True Health New Mexico Pharmacy Services at 1-866- 341-8561 for quantity limits on specialty medications. Maximum
More informationALLERGIC RHINITIS-NASAL
ALLERGIC RHINITIS-NASAL FLUNISOLIDE Patient needs to have paid claims for any one of the following Step 1 drugs: NasaCort OTC, fluticasone Rx, fluticasone OTC, Budesonide OTC. Prior to filling the Step
More informationDEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL
DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code
More informationAetna Better Health of Illinois Medicaid Formulary Updates
December 2016 Aetna Better Health f Illinis Medicaid 2016 Frmulary Updates Frmulary Additins Nilutamide tab 150MG Nitrglycerin SL (all strengths) Erythrmycin Ethylsuccinate Sus 200/5ML ABACAVIR SULFATE-LAMIVUDINE
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 May 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 9 May 2012 EDURANT 25 mg film-coated tablets B/30 (CIP code: 219 472-9) Applicant: JANSSEN-CILAG rilpivirine ATC code
More informationHIV Integrase Inhibitors: Current and Future Use. Douglas G. Fish, MD Albany Medical College Cali, Colombia March 13, 2008
HIV Integrase Inhibitors: Current and Future Use Douglas G. Fish, MD Albany Medical College Cali, Colombia March 13, 2008 Which of the following statements about raltegravir is false? a) Raltegravir is
More information0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920
0.14 UNAIDS 0.053% 2 250 60 10% 94 73 20 73-94/6 8,920 12 43 Public Health Service Task Force Recommendations 5-10% for Use of Antiretroviral Drugs in 10-20% Pregnant HIV-1-Infected Women for Maternal
More informationDrug Class Preferred Agents Non-Preferred Agents
Commissioner for the Department for Medicaid Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Commissioner of the Department for
More informationProjeto Praça Onze Universidade Federal do Rio de Janeiro. Long term treatment of chronic viral disease: lessons from HIV for HBV
Projeto Praça Onze Universidade Federal do Rio de Janeiro Long term treatment of chronic viral disease: lessons from HIV for HBV Mauro Schechter Principal Investigator, Projeto Praça Onze Professor of
More informationSculpting a Better Regimen: The ART of HIV Medications
Sculpting a Better Regimen: The ART of HIV Medications Kelly Peddy, PharmD, MPA Clinical Pharmacy Specialist - Ambulatory Care Memorial Hospital of South Bend November 30, 2017 For HealthTrust Members
More information30 Years of HIV: An Update on Treatment Guidelines and Beyond
8/3/212 Conflict of Interest Declaration 3 Years of HIV: An Update on Treatment Guidelines and Beyond Blake Max, PharmD, AAHIVE Clinical Associate Professor University of Illinois at Chicago College of
More informationApproach to a Patient Newly Diagnosed with HIV, Including ART Basics Rajesh T. Gandhi, M.D.
Approach to a Patient Newly Diagnosed with HIV, Including ART Basics Rajesh T. Gandhi, M.D. Disclosures: grant support from Gilead, Roche, EBSCO Objectives Apply current guidelines to initial evaluation
More informationSovaldi + Olysio + ribavirin Harvoni + ribavirin. Sovaldi + ribavirin Viekira Pak
Hepatitis Prior Authorization Request CVS Caremark administers the specialty pharmacy benefit plan for the patient identified. This patient s benefit plan requires prior authorization for certain medications
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More informationINDEX. indications...11 initiation of metabolic and morphologic complications
Index 287 INDEX 3TC...245 246 3TC/FTC...66 67 Abacavir...68, 218 Abacavir + lamivudine...219 220 Abacavir + lamivudine + zidovudine...220 ABC...218 Absolute neutrophil counts (ANC)...136, 137 Acidosis,
More information2018 WPS MedicareRx Plan (PDP) Step Therapy
2018 WPS MedicareRx Plan (PDP) Step Therapy In some cases, the WPS MedicareRx Plan (PDP) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that
More informationSelecting an Initial Antiretroviral Therapy (ART) Regimen
Selecting an Initial Antiretroviral Therapy (ART) Regimen An HIV Diagnosis is a Call to Action In support of the NYSDOH AIDS Institute s January 2018 call to action for patients newly diagnosed with HIV,
More informationNSAID all (Warner-Schmidt) includes all (NSAIDs, Salicytes, and Cox-2 inhibitors)
Table S1. Medications categorized as s all (Warner-Schmidt) includes all (s, Salicytes, and Cox-2 inhibitors) Nonsteroidal anti-inflammatory agents Bromfenac Diclofenac Diclofenac-misoprostol Etodolac
More informationCOLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet
COLCRYS-PST Mitigare 0.6 mg capsule Colcrys 0.6 mg tablet Criteria If the patient has tried one Step 1 product, authorization for a Step 2 product may be given. Exceptions can be made for a step 2 drug
More information